Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia
Clinical trial NCT06072040 · TERMINATED
Trial details
- NCT number
- NCT06072040
- Sponsor
- Auregen Biotherapeutics, SA
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-26
- Primary completion
- 2025-11-14
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.